Uncategorized

North America Continuous Glucose Monitoring Systems (CGMS) Market is expected to grow at a CAGR of 28.1% during 2016-2022

According to a  new report, “North America Continuous Glucose Monitoring Systems (CGMS) Market”, published by KBV Research, the North America Continuous Glucose Monitoring Systems Market is expected to grow at a CAGR of 28.1% during 2016 -2022.

The Sensors market dominated the North America Continuous Glucose Monitoring Systems Market in 2015, and would grow at a CAGR of 29.4% during the forecast period. The U.S market registered the largest revenue share in the North America Continuous Glucose Monitoring Systems Sensors Market in 2015, and is expected to grow at a CAGR of 28.5% during the forecast period. The Canada market is expected to attain a market size of $146.5 million by 2022. However, Mexico market is expected to grow at CAGR of 31.1% during 2016-2022.

The Diagnostic centers/clinics segment is expected to attain a market size of $606.8 million by 2022. However, Home Healthcare market is expected to grow at CAGR of 40.2% during 2016-2022.The ICUs market followed the Diagnostic centers/clinics market in the North America Continuous Glucose Monitoring Systems Market in 2015.

The report highlights the adoption of Continuous Glucose Monitoring Systems (CGMS) in North America.Based on the Component, the Global Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are U.S, Canada, Mexico and Rest of North America region.

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Full report: https://kbvresearch.com/reportDetail.php?content_id=north-america-continuous-glucose-monitoring-systems–cgms–market

Research Scope

The market is segmented based on Component, End User and Country.

North America Continuous Glucose Monitoring Systems Market, by Component

  • Hardware
  • Software
  • Services

North America Continuous Glucose Monitoring Systems Market, by End User

  • Displays Terminals
  • Interface Software
  • Industrial PCs
  • Other Controllers

North America Continuous Glucose Monitoring Systems Market, by Country

  • U.S
  • Canada
  • Mexico
  • Rest of North America

Company Profiles

  • Roche Diagnostics
  • Abbott Laboratories
  • Dexcom Inc.
  • Novo Nordisk
  • Ypsomed AG
  • GlySens Incorporated
  • Medtronic Plc and
  • Johnson & Johnson
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s